Abstract
Objectives
Bleeding is the most common complication of percutaneous nephrolithotomy (PCNL). Injudicious transfusion is frequently performed in current practice, even though it is not always needed. This study aimed to identify the predictive factors of blood loss in the PCNL procedure and evaluate the perioperative transfusion practice.
Methods
A prospective study of PCNL was randomly performed by two consultants of endo-urology at our institution. The inclusion criteria were adults with kidney pelvic stones >20 mm or stone in inferior calyx >10 mm or staghorn stone. Those with coagulopathy, under anti-coagulant treatment or open conversion were excluded. A full blood count was taken at baseline and during 12, 24, 36, 72-hours post-operatively. Factors such as stone burden, sex, body surface area, shifting of hematocrit level and amount of blood transfused were analyzed statistically using line regression to identify the predictive factors of total blood loss (TBL).
Results
Eighty-five patients were enrolled in this study. Mean TBL was 560.92 ± 428.43 mL for both endo-urology surgeons. Stone burden was the most influential factor for TBL (p=0.037). Our results revealed that TBL (mL) = -153.379 + 0.229 × stone burden (mm2) + 0.203 x baseline serum hematocrit (%); thus considerably predicted the need for blood transfusion. A total of 87.1% patients did not receive perioperative transfusion, 3.5% received intra-operative transfusion, 7.1% received post-operative transfusion, 23% had both intra and post-operative transfusion, resulting in a cross-matched transfusion ratio of 7.72. Mean perioperative blood transfused was 356.00 ± 145.88 mL.
Keywords: Bleeding, nephrolithiasis, PCNL, transfusion
Introduction
Kidney stones prove to be a common affliction in many countries worldwide because of high incidence and prevalence. In America, kidney stone incidence was found in 116 out of 100,000 individuals 1. A higher incidence was discovered in the German population aged 14 years and older, amounting to 720 out of 100,000 individuals 2. An excessively high number of cases was found in Asian countries, namely, 114.3 per 100,000 in Japan, while Iranian urolithiasis incidence was assessed at 145.1 in 2005 3. A global increase in kidney stone cases was determined in individuals of all ages, sex, and races 4. In our institution we have, to date, treated an increasing number of kidney stone patients, from 182 in 1997 to 847 in 2002 5.
Percutaneous nephrolithotomy (PCNL) is a urological minimally-invasive procedure to extract kidney stones by means of percutaneous access 6. Nowadays, PCNL is widely accepted to treat those complex kidney stone cases that are hard in consistency, of a large size, infected, obstructed with anatomical abnormalities, generally cases that could not be treated by other modalities 7. In European guidelines, PCNL is favoured as the treatment of choice for calyx and pelvic stones >20 mm 2 8. For stones >20 mm, PCNL demonstrated a stone-free rate up to 78–95% 9. There has been a decrease in open surgery number in our institution during 2001–2009, whereby the PCNL procedure has become more frequent 10.
One of the most bothersome complications of PCNL is hemorrhage. Direct access to the pelvicalyceal system and intrarenal manipulation during PCNL procedures cause injury to the renal vasculature, particularly to the segmental and interlobar arteries. The renal-collecting system is rich in vascularization, covering 20% of the total cardiac output, and often results in hemorrhage during PCNL 11. The high percentage of blood loss and the necessity of transfusion often results in the erroneous management of hemorrhage during the PCNL procedure.
It has been reported that 1–11% of patients who underwent PCNL required blood transfusion; a higher transfusion rate, 2–53% was determined in the staghorn cases 11. Previous studies describe many hemorrhage risk factors during PCNL, such as, age 12, pre-operative urinary tract infections 12, large stones (exceeding 1250 mm 2) 13, staghorn calculi 13, 14, multiple access 11, 13, 14, diabetes mellitus 11, 13, 15, prolonged surgery time 11– 13 and stone composition 13. Other risk factors have been postulated: i.e. stone location, pre-operative hemoglobin, hydronephrosis grade, renal parenchymal thickness, however, to date, have not yet been proven. Many of the hemorrhage cases during PCNL could be managed conservatively, however, 0.8% patients required a more invasive procedure to deal with the bleeding 14.
To date there are no specific data available to determine the blood transfusion requirement during PCNL procedures. In our institution, blood units are requested pre-operatively according to clinical estimation. However, this does not always concede to the intra-operative blood loss. This study was aimed at predicting the amount of blood loss during PCNL by identifying the pre-operative factors that could possibly lead to a lower morbidity rate.
Materials and methods
The present study includes patients who underwent percutaneous nephrolithotomy procedure in our hospital from October 2012 to October 2013. Adult patients (≥18 years old) with pelvic stones >20 mm, inferior calyx stones >10 mm or staghorn stones who agreed to enroll by written informed consent were included in this study. Those with coagulopathy, under anti-coagulant treatment or conversion to open procedure were excluded.
Patients were admitted the day prior to procedure. Stone burden was assessed pre-operatively by multiplying sum of length and width by means of imaging. The PCNL was randomly performed under spinal anesthesia by two endo-urology consultants. The patient was placed in prone position, access gained to pelvicalyceal system with fluoroscopic guidance, followed by dilatation using a metal and fascia dilator before application of sheath. The number and location of punctures were decided intra-operatively, based on pelvicalyceal system. We used pneumatic lithotripsy to break the stone which was subsequently extracted by forceps or grasper. The procedure was completed when the patient was stone-free and any arising complications alleviated.
Full blood counts were taken prior to procedure and thereafter at 12, 24, 36, 72-hours post-operatively. Total blood loss was calculated considering body surface area, sex-adjusted estimated blood volume, initial hematocrit level and 72-hour post-operative hematocrit level. Study protocol has been approved by the Ethical Committee, Faculty of Medicine, Universitas Indonesia (No.89/H2.F1/ETIK/2013).
We compiled a chart 15, 16 to assess total blood loss (TBL) to include sex, body surface area, shifting of hematocrit level and amount of blood transfused, as shown in Table 1.
Table 1. Operational definition.
| Variable | Formula |
|---|---|
| Body Surface Area (m 2) 15 | 0.0235 × [Height (cm)] 0.42246 × [BW (kg)] 0.51456 |
| Estimated Blood Volume (mL) 15 | Female: [Body Surface Area (m 2)] × 2430 |
| Male: [Body Surface Area (m 2)] × 2530 | |
| Initial RBC (mL) 15 | [Estimated Blood Volume (mL)] × [Initial Hematocrit level 24-hour pre-op (%)] |
| Final RBC (mL) 15 | [Estimated Blood Volume (mL)] ×[Final Hematocrit level 72-hour post-op (%)] |
| Uncompensated RBC Loss (mL) 15 | [Initial RBC (mL)] – [Final RBC (mL)] |
| Compensated RBC Loss (mL) 15 | [Amount of RBC transfused from intra-op to 72-hour post-op] |
| Total RBC Loss (mL) 15 | [Uncompensated RBC Loss (mL)] + [Compensated RBC Loss (mL)] |
| Total Blood Loss (mL) 16 | |
| Cross match transfusion ratio/CT
ratio 17 |
Amount of blood unit cross-matched : Amount of blood unit transfused |
| Under-transfusion 18 | Defined as blood volume transfused deficit less than 15.0% of total blood loss (mL) |
| Over-transfusion 18 | Defined as blood volume transfused excess greater than 15.0% of total blood loss (mL) |
Abbreviations: RBC = red blood cell, BW = body weight
Bivariate analysis was done by correlating numerical variables with total blood loss, and associating categorical variables with perioperative blood transfusion amount. Those with significancy of <0.25 were further analyzed with multivariate analysis of linier and logistic regression.
Results
A total of 85 PCNL procedures were performed on 85 patients (46 males, 39 females) who completed this study, thus gave statistical power of 0.8. The average age was 50.96 ± 11.87 years. Most of the patients complained of flank pain at initial presentation ( Table 2). Staghorn calculi were found in 50.6% patients.
Table 2. Patient Characteristics (n=85).
| Variable | Number (Percentages) | ||
|---|---|---|---|
| Sex | Male | 46 (54.1%) | |
| Female | 39 (45.9%) | ||
| Symptoms | Renal colic | 17 (20.2%) | |
| Flank pain | 76 (89.3%) | ||
| Passing stone | 29 (34.5%) | ||
| Sandy urination | 10 (11.9%) | ||
| Haematuria | 18 (21.4%) | ||
| Dysuria | 3 (3.6%) | ||
| Fever | 4 (4.8%) | ||
| Urinary retention | 2 (2.4%) | ||
| Intermittency | 2 (2.4%) | ||
| Stone Side | Right | 50 (59.0%) | |
| Left | 35 (41.0%) | ||
The mean hematocrit drop was 5.20 ± 3.36%. Average total blood loss was 560.92 ± 428.43 mL with median 511.46 (95% CI: 0.00-1974.84) mL. There were two cases with pelvicalyceal laceration, one with massive hemorrhage (perioperative blood loss 1974.84 mL). There was no significant difference of total blood loss between the cases performed by the two PCNL surgeons (p>0.05).
Stepwise multivariate regression analysis which included variables with p-value < 0.25 ( Table 3) showed that stone burden was the most influential predictor of blood loss (p=0.037). Meanwhile operative time was found not associated (p-value >0.05) with blood loss. We assessed total blood loss (in mL) as -153.379 + 0.229 × stone burden (mm 2) + 0.203 × serum hematocrit baseline (%). This means it is predicted that a kidney stone patient with 1000 mm 2 stone burden and baseline hematocrit 40% will have 83.74 mL blood loss during PCNL procedure perioperative.
Table 3. Bivariate analysis between related factors and total blood loss.
| Variable | p-Value | R |
|---|---|---|
| Stone burden** | 0.067 | 0.200 |
| Number of stones** | 0.380 | 0.096 |
| Serum creatinine baseline** | 0.549 | 0.066 |
| Red blood cell count** | 0.095 | 0.182 |
| Serum hematocrit baseline* | 0.135 | 0.163 |
| Serum hemoglobin baseline** | 0.501 | 0.074 |
| Body mass index** | 0.298 | 0.114 |
| Age* | 0.670 | 0.047 |
*Pearson analysis **Spearman analysis
The average amount of blood units 435.29 ± 114.13 mL was cross-matched for each procedure pre-operatively ( Table 4). Nevertheless, 87.1% of patients did not receive blood transfusion perioperatively, thus yielding the blood transfusion rate as 12.9%. Blood transfusion was required by 3.5% patients intra-operatively, 7.1% post-operatively and 2.3% both intra and post-operatively. In total, the cross-matched transfusion ratio was 7.72. The average amount of blood transfused during PCNL procedure: 356.00 ± 145.88 mL.
Table 4. Blood transfusion pattern.
| Blood Transfusion
Proportion (%) |
Average amount of
blood unit cross- matched |
Average amount of blood
transfused (Intra-op – 72-hour post-op) |
>Under-
transfusion (%) |
>Over-
transfusion(%) |
|
|---|---|---|---|---|---|
| No transfusion | 87.1% | 435.29 ± 114.13 mL | 356.00 ± 145.88 mL | 0% | 100% |
| Intra-operative
transfusion |
3.5% | Cross Match Transfusion Ratio | |||
| Post-operative
transfusion |
7.1% | 7.72 | |||
| Both intra &
post-operative transfusion |
2.3% | ||||
The raw data of the bivariate analysis between related factors and total blood loss are provided.
Copyright: © 2016 Syahputra FA et al.
Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
The raw data for ‘Blood transfusion practice’ are provided.
Copyright: © 2016 Syahputra FA et al.
Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
Discussion
In this study we did not use conventional, visual estimated blood loss to determine hemorrhage due to high bias factors, subjectivity, persistence of dilution effect and poor accuracy 19– 23. Laboratory parameters in our study were recorded until 72-hours post-operatively, in order to minimize intravenous hydration and retroperitoneal fluid absorption effects. We used the hematocrit level as the main parameter to determine blood loss rather than hemoglobin to avoid hemodilution effect 15, 24; Furthermore, the hematocrit level positively correlated with the total blood volume 25. It has been reported that also a center in Turkey applies a blood transfusion policy that depends on the hematocrit level (transfusion was indicated when hematocrit level was less than 30%) 14.
Stone burden was the most influential predictive factor for blood loss during the PCNL procedure in this study, similar to other studies performed. A multivariate analysis showed that complete and partial staghorn calculi were associated with a greater blood loss than with the calyx stones 14. Other studies concluded that larger stone burdens 11 or staghorn calculi 26 required a greater amount of unit blood transfused during the PCNL procedure compared to the smaller stones. Greater hematocrit level changes in staghorn calculi were found during PCNL, while further multivariate tests concluded that staghorn calculi were associated with a greater amount of blood loss (OR 1.92) and a greater decrease in the hemoglobin level compared to non-staghorn cases 13. Prolonged and excessive intra-renal maneuver performed for large stone burdens was assumed to increase incidence of injury to renal vasculature 11.
Our transfusion rate was similar to the one reported in a retrospective study from Pakistan showing an overall blood transfusion rate of 14.2% with one angioembolization performed to control hemorrhage 26. In our study, all cases presenting with massive hemorrhage could be managed conservatively. Lower blood transfusion rates were reported in two other studies from Pakistan, one study from United Kingdom and one study from the United States; these differences occurred due to the younger age group 27, supine position used 28 and balloon dilatation 29, 30. A higher transfusion rate (23.8%) compared to our result was shown in a retrospective analysis. An aggressive approach by torqueing the rigid nephroscope to maximize stone clearance at one stage was explained 14.
A precise estimation of surgical blood loss is essential in order to avoid excessive usage of blood units. Most of the previous studies emphasize the estimated blood loss rather than the objective prediction. Our calculation of total blood loss included perioperative factors: the patient’s blood volume (based on sex, body weight and height), the number of red cell units transfused, the hematocrit changes, and the amount of hemodilution. To our knowledge, this is the first study that has applied a mathematical approach to predict blood loss during PCNL procedures. We did not include hydronephrosis grading, parenchymal thickness and stone composition to analyze the predictive factors of blood loss, due to the possible limitations relating to our study.
Conclusions
Stone burden was the most influential PCNL blood loss predictive factor in our institution. We estimated that the amount of blood requested and cross-matched for PCNL is much greater than the actual blood loss. Our principle was proposed as a guidance to reduce any unnecessary costs and excessive requirements of blood units.
Consent
Written informed consent to participate in the study and publish clinical data was obtained by the patients.
Data availability
The data referenced by this article are under copyright with the following copyright statement: Copyright: © 2016 Syahputra FA et al.
Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication). http://creativecommons.org/publicdomain/zero/1.0/
F1000Research: Dataset 1. Raw data for Table 3 of 'Blood loss predictive factors and transfusion practice during percutaneous nephrolithotomy of kidney stones', 10.5256/f1000research.8993.d127629 31
F1000Research: Dataset 2. Raw data for Table 4 of 'Blood loss predictive factors and transfusion practice during percutaneous nephrolithotomy of kidney stones', 10.5256/f1000research.8993.d127630 32
Funding Statement
Cipto Mangunkusumo Hospital Operational Research Grant 2013 funded this research.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
[version 1; referees: 1 approved
References
- 1. Saigal CS, Joyce G, Timilsina AR, et al. : Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int. 2005;68(4):1808–14. 10.1111/j.1523-1755.2005.00599.x [DOI] [PubMed] [Google Scholar]
- 2. Hesse A, Brändle E, Wilbert D, et al. : Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol. 2003;44(6):709–13. 10.1016/S0302-2838(03)00415-9 [DOI] [PubMed] [Google Scholar]
- 3. Yasui T, Iguchi M, Suzuki S, et al. : Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology. 2008;71(2):209–13. 10.1016/j.urology.2007.09.034 [DOI] [PubMed] [Google Scholar]
- 4. Romero V, Akpinar H, Assimos DG: Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12(2–3):e86–96. [PMC free article] [PubMed] [Google Scholar]
- 5. Rahardjo D: Perkembangan penatalaksanaan batu ginjal di RSCM tahun 1997–2002. J I Bedah Indones. 2004;32:58–63. [Google Scholar]
- 6. Gupta M, Ost M, Shah J, et al. : Percutaneous management of the upper urinary tract. In Wein A, Novick A and Peters C: Campbell's urology.Philadelphia, W.B. Saunders Co,2007;1526–1563. [Google Scholar]
- 7. Skolarikos A, Alivizatos G, de la Rosette JJ: Percutaneous nephrolithotomy and its legacy. Eur Urol. 2005;47(1):22–8. 10.1016/j.eururo.2004.08.009 [DOI] [PubMed] [Google Scholar]
- 8. Türk C, Knoll T, Petrik A, et al. : Guidelines on Urolithiasis. 2013;5:19–40. Reference Source [Google Scholar]
- 9. Preminger GM, Assimos DG, Lingeman JE, et al. : Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol. 2005;173(6):1991–2000. 10.1097/01.ju.0000161171.67806.2a [DOI] [PubMed] [Google Scholar]
- 10. Birowo P, Rasyid N: Sekilas perjalanan hidup dr. Rochani, Sp.B, Sp.U(K). In Birowo P: Purna bakti dr. Rochani, Sp.B, Sp.U(K).Jakarta, Divisi Urologi Departemen Ilmu Bedah FKUI/Departemen Urologi RSCM,2010. [Google Scholar]
- 11. Kukreja R, Desai M, Patel S, et al. : Factors affecting blood loss during percutaneous nephrolithotomy: prospective study. J Endourol. 2004;18(8):715–22. 10.1089/end.2004.18.715 [DOI] [PubMed] [Google Scholar]
- 12. Keoghane SR, Cetti RJ, Rogers AE, et al. : Blood transfusion, embolisation and nephrectomy after percutaneous nephrolithotomy (PCNL). BJU Int. 2013;111(4):628–32. 10.1111/j.1464-410X.2012.11394.x [DOI] [PubMed] [Google Scholar]
- 13. Akman T, Binbay M, Sari E, et al. : Factors affecting bleeding during percutaneous nephrolithotomy: single surgeon experience. J Endourol. 2011;25(2):327–33. 10.1089/end.2010.0302 [DOI] [PubMed] [Google Scholar]
- 14. Turna B, Nazli O, Demiryoguran S, et al. : Percutaneous nephrolithotomy: variables that influence hemorrhage. Urology. 2007;69(4):603–7. 10.1016/j.urology.2006.12.021 [DOI] [PubMed] [Google Scholar]
- 15. Rosencher N, Kerkkamp HE, Macheras G, et al. : Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003;43(4):459–69. 10.1046/j.1537-2995.2003.00348.x [DOI] [PubMed] [Google Scholar]
- 16. Hurle R, Poma R, Maffezzini M, et al. : A simple mathematical approach to calculate blood loss in radical prostatectomy. Urol Int. 2004;72(2):135–9. 10.1159/000075967 [DOI] [PubMed] [Google Scholar]
- 17. Khan FA, Khan M, Ali A, et al. : Estimation of blood loss during Caesarean section: an audit. J Pak Med Assoc. 2006;56(12):572–5. [PubMed] [Google Scholar]
- 18. Seruya M, Oh AK, Rogers GF, et al. : Blood loss estimation during fronto-orbital advancement: implications for blood transfusion practice and hospital length of stay. J Craniofac Surg. 2012;23(5):1314–7. 10.1097/SCS.0b013e31825bd02a [DOI] [PubMed] [Google Scholar]
- 19. Poletajew S, Antoniewicz AA: Blood loss during laparoscopic radical prostatectomy - is it significant or not? Cent European J Urol. 2012;65(1):11–13. 10.5173/ceju.2012.01.art3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. McCullough TC, Roth JV, Ginsberg PC, et al. : Estimated blood loss underestimates calculated blood loss during radical retropubic prostatectomy. Urol Int. 2004;72(1):13–16. 10.1159/000075266 [DOI] [PubMed] [Google Scholar]
- 21. Stafford I, Dildy GA, Clark SL, et al. : Visually estimated and calculated blood loss in vaginal and cesarean delivery. Am J Obstet Gynecol. 2008;199(5):519.e1–7. 10.1016/j.ajog.2008.04.049 [DOI] [PubMed] [Google Scholar]
- 22. Gharoro EP, Enabudoso EJ: Relationship between visually estimated blood loss at delivery and postpartum change in haematocrit. J Obstet Gynaecol. 2009;29(6):517–520. 10.1080/01443610903003159 [DOI] [PubMed] [Google Scholar]
- 23. Schorn MN: Measurement of blood loss: review of the literature. J Midwifery Womens Health. 2010;55(1):20–27. 10.1016/j.jmwh.2009.02.014 [DOI] [PubMed] [Google Scholar]
- 24. Kukreja R, Desai M, Patel S, et al. : Factors affecting blood loss during percutaneous nephrolithotomy: prospective study. J Endourol. 2004;18(8):715–722. 10.1089/end.2004.18.715 [DOI] [PubMed] [Google Scholar]
- 25. Turna B, Nazli O, Demiryoguran S, et al. : Percutaneous nephrolithotomy: variables that influence hemorrhage. Urology. 2007;69(4):603–607. 10.1016/j.urology.2006.12.021 [DOI] [PubMed] [Google Scholar]
- 26. Zehri AA, Biyabani SR, Siddiqui KM, et al. : Triggers of blood transfusion in percutaneous nephrolithotomy. J Coll Physicians Surg Pak. 2011;21(3):138–41. [PubMed] [Google Scholar]
- 27. Mahmud M, Zaidi Z: Percutaneous nephrolithotomy in children before school age: experience of a Pakistani centre. BJU Int. 2004;94(9):1352–4. 10.1111/j.1464-410X.2004.05173.x [DOI] [PubMed] [Google Scholar]
- 28. Rana AM, Bhojwani JP, Junejo NN, et al. : Tubeless PCNL with patient in supine position: procedure for all seasons?--with comprehensive technique. Urology. 2008;71(4):581–5. 10.1016/j.urology.2007.10.059 [DOI] [PubMed] [Google Scholar]
- 29. Armitage JN, Irving SO, Burgess NA, et al. : Percutaneous nephrolithotomy in the United kingdom: results of a prospective data registry. Eur Urol. 2012;61(6):1188–93. 10.1016/j.eururo.2012.01.003 [DOI] [PubMed] [Google Scholar]
- 30. Tomaszewski JJ, Smaldone MC, Schuster T, et al. : Factors affecting blood loss during percutaneous nephrolithotomy using balloon dilation in a large contemporary series. J Endourol. 2010;24(2):207–11. 10.1089/end.2009.0402 [DOI] [PubMed] [Google Scholar]
- 31. Syahputra FA, Birowo P, Rasyid N, et al. : Dataset 1 in: Blood loss predictive factors and transfusion practice during percutaneous nephrolithotomy of kidney stones: a prospective study. F1000Research. 2016. Data Source [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Syahputra FA, Birowo P, Rasyid N, et al. : Dataset 2 in: Blood loss predictive factors and transfusion practice during percutaneous nephrolithotomy of kidney stones: a prospective study. F1000Research. 2016. Data Source [DOI] [PMC free article] [PubMed] [Google Scholar]
